Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

UNICHEM LABORATORIES LTD.

NSE : UNICHEMLABBSE : 506690ISIN CODE : INE351A01035Industry : Pharmaceuticals & DrugsHouse : Private

BSE442.9564.9 (+17.17 %)

PREV CLOSE ( ) 378.05

OPEN PRICE ( ) 380.00

BID PRICE (QTY) 442.20 (4)

OFFER PRICE (QTY) 442.95 (249)

VOLUME 126690

TODAY'S LOW / HIGH ( )378.85 447.00

52 WK LOW / HIGH ( )280 666

NSE441.0061.35 (+16.16 %)

PREV CLOSE( ) 379.65

OPEN PRICE ( ) 379.00

BID PRICE (QTY) 440.65 (500)

OFFER PRICE (QTY) 440.95 (1)

VOLUME 2968566

TODAY'S LOW / HIGH( ) 376.60 447.45

52 WK LOW / HIGH ( )278.2 666.6

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-08 1962

Management Info

Prakash A Mody - Chairman Pabitrakumar Kalipada Bhattacharyya - Managing Director

Registered Office

Address 47,Kandivli Industrial Estate,Kandivli (West),
Mumbai,
Maharashtra-400067

Phone 022 - 66474100

Email shares@unichemlabs.com

Website www.unichemlabs.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

13Apr Unichem Laboratories’ arm recalls 500-
Unichem Laboratories’ wholly-owned-subsidiary -- Unichem Pharmaceuticals..

07Apr Unichem Laboratories informs about ce
Unichem Laboratories has informed that it enclosed a certificate dated A..

30Mar Unichem Laboratories informs about scr
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure..

24Mar Unichem Laboratories informs about tra
Unichem Laboratories has informed that the Trading Window for dealing in..

25Feb Unichem Laboratories informs about pos
Unichem Laboratories has informed that it enclosed the Postal Ballot Not..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	-153.9	1589.4
Gross Profit	-107.100000000001	2094.1
Operating Profit	347.099999999999	1132.6
Net Sales	3562.4	14122.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kwality Pharma (BSE) 2498.25 (6.93%)	M.Cap ( in Cr)2592.23
Abbott India (BSE) 26250.00 (0.40%)	M.Cap ( in Cr)55811.29
Venus Remedies (BSE) 1682.35 (5.00%)	M.Cap ( in Cr)2248.80
Caplin Point Lab (BSE) 2331.00 (3.25%)	M.Cap ( in Cr)17748.73
Concord Biotech (BSE) 1344.85 (5.76%)	M.Cap ( in Cr)14069.31

Shareholding Pattern

	PROMOTERS	70.22%
	NON-INSTITUTION	18.15%
	MUTUAL FUNDS/UTI	9.07%
	FI/BANKS/INSURANCE	0.25%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund...	1.64
HDFC Small Cap Fund...	0.90
Quant Value Fund-Reg(G)	0.48
ICICI Pru Pharma He...	0.15
Motilal Oswal BSE H...	0.09
Bandhan BSE Healthc...	0.09

Risk Disclosures on Derivatives

Smart Quotes

UNICHEM LABORATORIES LTD.